台股 » 個股 » 東洋 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

東洋

(4105)
可現股當沖
  • 股價
    77.8
  • 漲跌
    ▼0.9
  • 漲幅
    -1.14%
  • 成交量
    847
  • 產業
    上櫃 生技醫療類股
  • 342人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
東洋 (4105)籌碼相關-富邦-屏東 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-屏東 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/10278.3000.0078.4028300.24%
2024/05/09178.4000.0078.0018280.12%
2024/05/080.178.0000.0078.600.18170.01%
2024/05/02177.7000.0077.6018070.12%
2024/04/298.177.10477.1577.304.18020.51%
2024/04/2600.00676.6276.60-6797-0.76%
2024/04/2500.000.276.8076.50-0.2799-0.02%
2024/04/194176.98176.8076.00408184.89%
2024/04/1800.000.677.1077.40-0.6799-0.07%
2024/04/15378.200.178.5078.002.97890.37%
2024/04/12578.2000.0078.2057830.64%
2024/04/1100.00178.3078.20-1782-0.13%
2024/04/1000.00078.4078.4007810.00%
2024/04/0900.00178.3078.30-1779-0.13%
2024/04/08178.7000.0078.8017700.13%
2024/03/28278.00078.5078.3027660.26%
2024/03/271581.4000.0081.50157052.13%
2024/03/26181.8000.0081.2016850.15%
2024/03/2100.00181.7081.80-1659-0.15%
2024/03/18380.9700.0081.1036440.47%
2024/03/15081.9000.0081.8006420.00%
2024/03/1400.00181.7081.90-1636-0.16%
2024/03/1200.00181.1081.30-1658-0.15%
2024/03/11181.0000.0080.8016680.15%
2024/02/23281.4000.0080.7026720.30%
2024/02/2200.00181.6081.40-1675-0.15%
2024/02/21281.20181.2081.1016650.15%
2024/02/2000.00280.9080.90-2668-0.30%
2024/01/310.577.9400.0077.800.57870.06%
2024/01/23177.8000.0077.9019820.10%
2024/01/18177.2000.0077.8011,1550.09%
2024/01/1700.00178.5078.20-11,168-0.09%
2024/01/1600.00579.3079.30-51,163-0.43%
2024/01/10179.2000.0079.4011,1840.08%
2024/01/08279.9000.0079.8021,2000.17%
2024/01/05280.200.180.4080.201.91,2310.16%
2024/01/0400.005079.7679.80-501,234-4.05%
2023/12/29480.3000.0080.4041,2430.32%
2023/12/133080.1800.0080.10301,2472.41%
2023/12/072081.6800.0081.10201,2471.60%
2023/12/06083.16083.1082.9001,2140.00%
2023/12/010.283.4000.0083.100.21,1880.02%
2023/11/28184.5000.0084.5011,1520.09%
2023/11/27383.67184.3083.6021,1340.18%
2023/11/24083.2000.0082.9001,1020.00%
2023/11/23282.6500.0082.8021,0940.18%
2023/11/2200.001082.1582.50-101,088-0.92%
2023/11/20082.001081.9081.70-101,068-0.93%
2023/11/17181.7000.0081.6011,0600.10%
2023/11/16281.902081.9781.70-181,054-1.71%
2023/11/15081.7000.0081.5001,0470.00%
2023/11/144181.1700.0081.20411,0373.95%
2023/11/132084.3000.0084.20209742.05%
2023/11/101084.7000.0084.70109611.04%
2023/11/091084.90485.0084.9069360.64%
2023/11/0800.002086.7085.80-20921-2.17%
2023/11/0700.002086.6086.30-20898-2.23%
2023/11/0200.00283.7583.80-2789-0.25%
2023/10/31184.6000.0083.9017440.13%
2023/10/302083.1000.0083.60207112.81%
2023/10/2700.002085.1083.00-20681-2.94%
2023/10/1800.00279.3079.00-2553-0.36%
2023/10/131.179.81179.7079.400.15530.01%
2023/09/06276.8000.0076.8026720.30%
2023/08/30475.9000.0075.8046740.59%
2023/08/1700.00175.0075.00-1706-0.14%
2023/08/16974.9300.0074.9097101.27%
2023/08/15075.4000.0075.3007090.00%
2023/08/14575.0000.0075.0057130.70%
2023/08/04475.5500.0075.9047120.56%
2023/08/02576.2000.0075.6057230.69%
2023/07/2800.000.177.0077.00-0.1713-0.01%
2023/07/21178.9000.0078.5017220.14%
2023/07/20178.5000.0078.9017260.14%
2023/07/17278.4000.0078.8027150.28%
2023/07/140.177.9000.0077.600.17080.01%
2023/07/112.177.6000.0077.602.17070.29%
2023/07/0500.00178.5078.10-1716-0.14%
2023/07/04178.5000.0078.5017080.14%
2023/06/3000.00179.0078.40-1688-0.15%
2023/06/29378.20277.5078.1016470.15%
2023/06/28176.5000.0077.1016500.15%
2023/06/27176.70276.7076.50-1659-0.15%
2023/06/260.176.1000.0075.800.16800.01%
2023/06/200.276.8000.0076.600.27010.03%
2023/06/160.176.9000.0076.400.17140.01%
2023/06/13176.3000.0076.5017280.14%
2023/06/12175.3000.0075.3017220.14%
2023/05/260.175.0000.0075.100.17590.01%
2023/05/250.175.6000.0075.100.17560.01%
2023/05/24275.7000.0075.7027610.26%
2023/05/2200.00176.0076.00-1763-0.13%
2023/05/11575.4000.0075.0057960.63%
2023/05/100.176.1000.0075.700.18080.01%
2023/05/040.177.3000.0077.300.18350.01%
2023/04/2000.00376.6776.30-3875-0.34%
2023/04/1000.00476.9076.80-4990-0.40%
台灣東洋營運三箭齊發 續領營收再增長Anue鉅亨-2024/03/20
東洋旗下膽道癌口服藥 2月起納健保給付Anue鉅亨-2024/01/31
東洋 相關文章